Charles G. Prober
- Epidemiology top 0.5%
- Herpesvirus Infections and Treatments 47
- Cytomegalovirus and herpesvirus research 36
- Pneumonia and Respiratory Infections 13
- Respiratory viral infections research 11
- Infectious Diseases top 1%
- Parvovirus B19 Infection Studies 20
- Virology top 2%
- Family Practice top 2%
- Endocrinology top 2%
-
- Innovations in Medical Education 14
-
- Antibiotics Pharmacokinetics and Efficacy 10
-
- Bacterial Infections and Vaccines 8
Charles G. Prober
130 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Epidemiology 3.5k
- Infectious Diseases 1.5k
- Virology 289
- Family Practice 99
- Endocrinology 230
Countries citing papers authored by Charles G. Prober
This map shows the geographic impact of Charles G. Prober's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles G. Prober with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles G. Prober more than expected).
Fields of papers citing papers by Charles G. Prober
This network shows the impact of papers produced by Charles G. Prober. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles G. Prober. The network helps show where Charles G. Prober may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles G. Prober, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 8 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 29 | |
| 5 | 2021 | 42 | |
| 6 | 2021 | 20 | |
| 7 | 2019 | 25 | |
| 8 | 2018 | 82 | |
| 9 | 2011 | 9 | |
| 10 | 2011 | 69 | |
| 11 | 2004 | 2 | |
| 12 | 2001 | 12 | |
| 13 | Aspergillus fumigatus wound infection in an immunocompetent child | 1999 | 1 |
| 14 | 1996 | 147 | |
| 15 | 1991 | 55 | |
| 16 | 1989 | 84 | |
| 17 | 1984 | 181 | |
| 18 | 1983 | 9 | |
| 19 | 1982 | 165 | |
| 20 | 1979 | 66 |
About Charles G. Prober
Charles G. Prober is a scholar working on Epidemiology, Infectious Diseases and Microbiology, having authored 133 papers that have together received 6.6k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (47 papers), Cytomegalovirus and herpesvirus research (36 papers), Parvovirus B19 Infection Studies (20 papers), Innovations in Medical Education (14 papers), Pneumonia and Respiratory Infections (13 papers), Respiratory viral infections research (11 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Bacterial Infections and Vaccines (8 papers). The work is most often cited by research in Epidemiology (3.5k citations), Infectious Diseases (1.5k citations) and Virology (289 citations). Charles G. Prober has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Ann M. Arvin, Chip Heath, Salman Khan, Anne S. Yeager, Henry Levison, Mary Corey, Linda L. Yasukawa, Ronald Gold, Alan Isles and Ian MacLusky. Their work appears in journals such as The Pediatric Infectious Disease Journal, The Journal of Pediatrics, Academic Medicine, New England Journal of Medicine and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.